Cargando…
Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Dermatologia
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007031/ https://www.ncbi.nlm.nih.gov/pubmed/31644629 http://dx.doi.org/10.1590/abd1806-4841.20198358 |
| _version_ | 1783495253883355136 |
|---|---|
| author | Kurizky, Patricia Shu Galvão, Letícia Oba Martins, Gladys Aires |
| author_facet | Kurizky, Patricia Shu Galvão, Letícia Oba Martins, Gladys Aires |
| author_sort | Kurizky, Patricia Shu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7007031 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Sociedade Brasileira de Dermatologia |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70070312020-02-13 Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up Kurizky, Patricia Shu Galvão, Letícia Oba Martins, Gladys Aires An Bras Dermatol Letters Sociedade Brasileira de Dermatologia 2019 /pmc/articles/PMC7007031/ /pubmed/31644629 http://dx.doi.org/10.1590/abd1806-4841.20198358 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivative License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited and the work is not changed in any way. |
| spellingShingle | Letters Kurizky, Patricia Shu Galvão, Letícia Oba Martins, Gladys Aires Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up |
| title | Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up |
| title_full | Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up |
| title_fullStr | Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up |
| title_full_unstemmed | Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up |
| title_short | Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up |
| title_sort | efficacy and safety of biosimilar infliximab ct-p13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007031/ https://www.ncbi.nlm.nih.gov/pubmed/31644629 http://dx.doi.org/10.1590/abd1806-4841.20198358 |
| work_keys_str_mv | AT kurizkypatriciashu efficacyandsafetyofbiosimilarinfliximabctp13inthetreatmentofpsoriasisandpsoriaticarthritis1yearfollowup AT galvaoleticiaoba efficacyandsafetyofbiosimilarinfliximabctp13inthetreatmentofpsoriasisandpsoriaticarthritis1yearfollowup AT martinsgladysaires efficacyandsafetyofbiosimilarinfliximabctp13inthetreatmentofpsoriasisandpsoriaticarthritis1yearfollowup |